Tenax Therapeutics, Inc.
TENX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000034956
In the last 90 days, Tenax Therapeutics, Inc. insiders filed 6 open-market purchases and 0 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $441.4M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Tenax Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +1 vs. Q3 2023
- Shares held
- 1.34M
- +718.7K (+115.2%) vs. Q3 2023
- Total value
- $367.6K
- +$182.8K (+98.9%) vs. Q3 2023
- New holders
- 7
- 4 more added
- Sold out
- 6
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TENX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $441.4M |
| Q1 2026 | 81 | $341.0M |
| Q4 2025 | 49 | $85.9M |
| Q3 2025 | 34 | $35.9M |
| Q2 2025 | 26 | $12.9M |
| Q1 2025 | 23 | $13.1M |
| Q4 2024 | 21 | $8.43M |
| Q3 2024 | 19 | $4.25M |
| Q2 2024 | 11 | $57.2K |
| Q1 2024 | 9 | $30.5K |
| Q4 2023 | 17 | $367.6K |
| Q3 2023 | 16 | $184.8K |
| Q2 2023 | 15 | $119.2K |
| Q1 2023 | 13 | $230.6K |
| Q4 2022 | 19 | $691.8K |
| Q3 2022 | 29 | $1.24M |
| Q2 2022 | 25 | $2.08M |
| Q1 2022 | 25 | $6.54M |
| Q4 2021 | 28 | $8.38M |
| Q3 2021 | 25 | $13.6M |
| Q2 2021 | 25 | $7.32M |
| Q1 2021 | 26 | $7.21M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Tenax Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Banque Cantonale Vaudoise | 50 | $0 | 0.00% | 00.0% | Unchanged |
| Tucker Asset Management LLC | 2 | $1 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 184 | $51 | 0.00% | +24+15.0% | Added |
| Qube Research & Technologies Ltd | 500 | $137 | 0.00% | +500 | New |
| Tower Research Capital LLC (TRC) | 4,558 | $1.25K | 0.00% | −95−2.0% | Reduced |
| HRT Financial LP | 20,765 | $5.00K | 0.00% | +20,765 | New |
| Morgan Stanley | 20,677 | $5.68K | 0.00% | +20,002+2,963.3% | Added |
| BlackRock Inc. | 23,922 | $6.57K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 42,524 | $11.7K | 0.00% | +42,524 | New |
| Citadel Advisors LLC | 50,556 | $13.9K | 0.00% | +35,523+236.3% | Added |
| Susquehanna International Group, LLP | 76,171 | $20.9K | 0.00% | +76,171 | New |
| State Street Corp | 95,067 | $26.1K | 0.00% | −55−0.1% | Reduced |
| Two Sigma Investments, LP | 142,371 | $39.1K | 0.00% | +142,371 | New |
| Geode Capital Management, LLC | 148,118 | $40.7K | 0.00% | +29,140+24.5% | Added |
| Vanguard Group Inc | 186,046 | $51.1K | 0.00% | +186,046 | New |
| CI Private Wealth, LLC | 190,959 | $52.4K | 0.00% | −501−0.3% | Reduced |
| Renaissance Technologies LLC | 340,167 | $93.0K | 0.00% | +340,167 | New |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −97,037−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −36,799−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Avantax Planning Partners, Inc. | 0 | $0 | 0.00% | −10,002−100.0% | Sold out |
| Lido Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −1−100.0% | Sold out |